 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 12 | 1/1 | 返回列表 |
| 查看: 268 | 回復(fù): 11 | |||
[交流]
【深容SCI寫作智能體】Abstract實測
|
|||
|
【深容SCI寫作智能體】Abstract實測 如需試用【深容SCI寫作智能體】，請聯(lián)系深容張老師：shenrongagent [https://scioriginal.com] 上月深容推出了【深容SCI寫作智能體】的Method，Introduction，Discussion智能體，寫作質(zhì)量非常高，全部真實參考文獻，深受用戶歡迎。 今天介紹的Abstract寫作智能體，功能相對簡單，根據(jù)用戶提供的正文內(nèi)容，快速起草摘要，同時輸出結(jié)構(gòu)式摘要和一體式摘要。 1. 用戶輸入正文內(nèi)容： 2. 檢索參考同類題材的摘要格式： 3. 輸出結(jié)果Abstract。 智能體的寫作質(zhì)量非常高： (1) Structured ABSTRACT 1) Background Signal Transducer and Activator of Transcription 2 (STAT2) is well-known for its role in type I interferon (IFN-I) signaling, which is generally considered tumor-suppressive. However, its direct role in cancer, particularly colorectal cancer (CRC), remains underexplored. Given the critical involvement of immune and cytokine networks in CRC progression, elucidating STAT2's contribution is essential. 2) Methods We analyzed TCGA-COAD datasets to assess STAT2 and IFNAR1 expression and patient survival. Human HCT116 and murine MC38 cell lines with STAT2 or IFNAR1 knockouts were generated using CRISPR\/Cas9 technology. Cell proliferation was measured in vitro using the CellTiter 96 assay. In vivo tumor growth was evaluated by subcutaneous injection of knockout and control cells into immunodeficient or immunocompetent mice. Western blot and qPCR analyses were performed to assess downstream signaling and gene expression changes. 3) Results High STAT2 expression in TCGA-COAD tumors correlated with reduced patient survival, independent of IFNAR1 levels. STAT2 deletion impaired cell proliferation and tumor growth in both human and murine models, whereas IFNAR1 deletion did not. STAT2 KO cells exhibited reduced STAT1 activation but enhanced STAT3 phosphorylation, indicating distinct downstream signaling effects compared to IFNAR1 KO cells. These findings suggest that STAT2 promotes tumorigenicity through mechanisms distinct from canonical IFN-I signaling. 4) Conclusion Our study reveals that STAT2 functions as a tumor-promoting factor in CRC, acting independently of IFNAR1-mediated IFN-I signaling. Targeting STAT2 or its downstream pathways may offer a novel therapeutic strategy for mitigating CRC progression. --- (2) Integrated ABSTRACT Signal Transducer and Activator of Transcription 2 (STAT2) is a key mediator of type I interferon (IFN-I) signaling, traditionally viewed as tumor-suppressive. However, its direct role in colorectal cancer (CRC) remains poorly defined, despite the critical influence of immune and cytokine networks on disease progression. To address this gap, we analyzed TCGA-COAD datasets and found that high STAT2 expression in CRC tumors correlated with reduced patient survival, independent of IFNAR1 levels. Using CRISPR\/Cas9 technology, we generated human HCT116 and murine MC38 cell lines with STAT2 or IFNAR1 knockouts. In vitro cell proliferation assays demonstrated that STAT2 deletion significantly impaired growth, whereas IFNAR1 deletion had no effect. In vivo studies in immunodeficient and immunocompetent mice confirmed that STAT2 KO cells formed smaller tumors compared to controls, while IFNAR1 KO cells did not differ significantly from wild-type cells. Western blot and qPCR analyses revealed that STAT2 deletion reduced STAT1 activation but enhanced STAT3 phosphorylation, indicating distinct downstream signaling effects compared to IFNAR1 KO cells. These findings suggest that STAT2 promotes tumorigenicity through mechanisms independent of canonical IFN-I signaling. Our study highlights STAT2 as a potential therapeutic target in CRC, offering new avenues for mitigating disease progression by targeting its pro-tumorigenic pathways. 以上這篇Abstract起草時間僅00:01:35 【深容SCI寫作智能體】包括四大模塊：Method智能體、Introduction智能體、Discussion智能體、Abstract智能體。 如需試用智能體，請徽售聯(lián)系深容張老師：shenrongagent [https://scioriginal.com] #SCI論文 #科研 #實驗 #博士 #投稿 |
回復(fù)此樓» 猜你喜歡
085600材料調(diào)劑 總分330
已經(jīng)有6人回復(fù)
-
歡迎211本科同學(xué)，過A區(qū)國家線，A區(qū)非偏遠一本，交叉學(xué)科課題組
已經(jīng)有30人回復(fù)
-
高分子化學(xué)與物理調(diào)劑
已經(jīng)有17人回復(fù)
-
化學(xué)專業(yè)調(diào)劑
已經(jīng)有6人回復(fù)
-
0703 東華大學(xué) 理學(xué)化學(xué)均過 a 線，總分 281 求調(diào)劑
已經(jīng)有11人回復(fù)
-
材料工程調(diào)劑
已經(jīng)有6人回復(fù)
-
材料學(xué)碩318求調(diào)劑
已經(jīng)有13人回復(fù)
-
08工科求調(diào)劑
已經(jīng)有4人回復(fù)
-
A區(qū)一本交叉課題組，低分調(diào)劑，招收機械電子信息通信等交叉方向
已經(jīng)有40人回復(fù)
-
070300調(diào)劑一志愿南京大學(xué)化學(xué)專業(yè)，初試273分，有論文有專利有競賽，求調(diào)劑B區(qū)211
已經(jīng)有11人回復(fù)
» 搶金幣啦！回帖就可以得到:
-
上海優(yōu)秀男生誠征結(jié)婚女友符合微信聯(lián)系
+3/862
-
中南大學(xué)材料院趙子謙課題組2026年招收碩博研究生、博士后研究員和科研助理
+1/185
-
湖北省楚天學(xué)子教授團隊招收專碩和學(xué)碩士6名
+5/135
-
中國科學(xué)院-材料計算小組尋求2026級研究生（包括調(diào)劑生/聯(lián)合培養(yǎng)等）
+5/95
-
廣東工業(yè)大學(xué)“有機光電材料與功能高分子團隊”招收2026年入學(xué)申請考核制博士生若干名
+1/80
-
2026年青島理工大學(xué)暖通專業(yè)碩士生招生_081404；0852；081300方向
+2/40
-
華南理工大學(xué)自旋科技研究院謝弘超課題組招收2026秋季博士、碩士研究生
+1/18
-
同濟大學(xué)環(huán)境學(xué)院肖倩研究員招收2026年碩士研究生
+1/16
-
【博士招生】武漢科技大學(xué)招收材料、化工、環(huán)境、冶金類2026年“申請-考核”制博士生
+1/16
-
26屆計算機、電子信息類、電科、控制、通信考研T j信息pp駿：74+08+76+6+20/
+1/14
-
26屆計算機、電子信息類、電科、控制、通信考研T j信息pp駿：74+08+76+6+20
+1/11
-
教育部長江學(xué)者和創(chuàng)新團隊發(fā)展計劃”入選團隊招收 材料，化學(xué)與化工博士研究生
+1/6
-
北京高校副校長團隊招收機械類，環(huán)境類學(xué)碩和專碩
+1/6
-
歡迎報考中山大學(xué)課題組，提供2026級碩士研究生名額
+1/5
-
電子科技大學(xué)巫江團隊招收博士研究生
+1/4
-
上海交通大學(xué)化學(xué)化工學(xué)院張智濤課題組誠聘博士后
+1/4
-
德國伊爾梅瑙工業(yè)大學(xué)（TU Ilmenau）柔性電子方向 誠邀CSC申請
+1/4
-
【以色列理工學(xué)院全額獎學(xué)金碩博士招生】王燕課題組 · 柔性可穿戴電子實驗室
+1/2
-
清華大學(xué)深圳國際研究生院張旻課題組招收2027級博士生_機械、儀器方向
+1/1
-
CSC-UTT : CNRS 法國國家科學(xué)研究中心/UTT 特魯瓦工程技術(shù)大學(xué) CSC博士phd全獎?wù)猩?/a>
+1/1
簡單回復(fù)
夏末末872樓
2026-01-11 18:20
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
1 發(fā)自小木蟲手機客戶端
2026-01-11 18:31
回復(fù)
jiaoxg4樓
2026-01-11 18:39
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
tfang5樓
2026-01-11 18:42
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
2026-01-11 18:51
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
2026-01-11 19:04
回復(fù)
toppaper8樓
2026-01-11 20:07
回復(fù)
XG-WUST9樓
2026-01-11 21:35
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
up 發(fā)自小木蟲IOS客戶端
psylhh10樓
2026-01-11 22:21
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
庚辰辛丑11樓
2026-01-12 07:28
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
afit88812樓
2026-01-12 11:17
回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 pheiphei2025 的主題更新
| 12 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 301求調(diào)劑 +6 | 朝天椒的雙馬尾 2026-03-05 | 6/300 |
|
|---|---|---|---|---|
|
|
[考研] 328求調(diào)劑 +6 | vuzhdkfjkx 2026-03-04 | 7/350 |
|
|
[考研] 085602 293分求調(diào)劑 +3 | SivanNano. 2026-03-05 | 3/150 |
|
|
|
[考研] 283求調(diào)劑 +10 | 鹿沫笙 2026-03-02 | 11/550 |
|
|
|
[考研] 一志愿清華深研院材料專碩294分，專業(yè)課111分，本科中南大學(xué)材料，有六級，有工作經(jīng)驗 +3 | H14528 2026-03-04 | 3/150 |
|
|
|
[考研] 281電子信息求調(diào)劑 +5 | jhtfeybgj 2026-03-02 | 9/450 |
|
|
|
[考研] 材料328求調(diào)劑 +10 | 一個蘿卜02 2026-03-03 | 10/500 |
|
|
|
[考研] 材料與化工，291分，求調(diào)劑 +9 | 咕嚕咕嚕123123 2026-03-04 | 11/550 |
|
|
|
[考研] 一志愿武漢理工大學(xué)-085602-總分296分-求調(diào)劑 +7 | 紫川葡柚 2026-03-04 | 7/350 |
|
|
|
[考研] 一志愿985材料與化工 326分求調(diào)劑 +3 | Hz795795 2026-03-04 | 3/150 |
|
|
|
[考研] 085600 材料與化工 298 +14 | 小西笑嘻嘻 2026-03-03 | 14/700 |
|
|
|
[考研] 295求調(diào)劑 +4 | 小賽不吃香菜 2026-03-04 | 4/200 |
|
|
|
[考研] 347分電子信息專碩求調(diào)劑 +3 | 咕嘟咕嘟1 2026-03-03 | 3/150 |
|
|
|
[考研] 291求調(diào)劑 +3 | 咕嚕咕嚕123123 2026-03-02 | 4/200 |
|
|
|
[考研] 化工專碩348，一志愿985求調(diào)劑 +8 | 弗格個 2026-02-28 | 11/550 |
|
|
|
[考研]
 計算機學(xué)碩 分數(shù)285求調(diào)劑
+4
|
glwshine 2026-03-02 | 5/250 |
|
|
|
[考研] 291求調(diào)劑 +3 | MuoLuo1312 2026-03-02 | 6/300 |
|
|
|
[考研] 295求調(diào)劑。一志愿報考鄭州大學(xué)化學(xué)工藝學(xué)碩，總分295分 +8 | yl1 2026-03-02 | 9/450 |
|
|
|
[考研] 化學(xué)，材料，環(huán)境類求調(diào)劑 +7 | 考研版棒棒 2026-03-02 | 7/350 |
|
|
|
[考研] 化工299分求調(diào)劑 一志愿985落榜 +5 | 嘻嘻(*^ω^*) 2026-03-01 | 5/250 |
|